GLYCOMIMETICS INC (GLYC)
US38000Q1022 - Common Stock
GlycoMimetics Announces Strategic Review and Corporate Restructuring Plan
7 Sorry Biotech Stocks Set to Make Investors Sad
Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!
GLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024
GLYC stock results show that GlycoMimetics missed analyst estimates for earnings per share the first quarter of 2024.
GLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips GlycoMimetics (NASDAQ:GLYC) just reported results for the first quarter of 2024...
Why Is Acutus Medical (AFIB) Stock Down 41% Today?
Acutus Medical stock is down on Monday after the company reported a delisting notice that will hit AFIB shares later this week.
Why Is GlycoMimetics (GLYC) Stock Down 77% Today?
GlycoMimetics stock is falling on Monday with heavy trading of GLYC after posting lackluster results from a Phase 3 trial of uproleselan.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Monday morning!
GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024
GLYC Stock Earnings: GlycoMimetics Beats EPS for Q4 2023
GLYC stock results show that GlycoMimetics beat analyst estimates for earnings per share the fourth quarter of 2023.
GLYC Stock Earnings: GlycoMimetics Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips GlycoMimetics (NASDAQ:GLYC) just reported results for the fourth quarter of 202...
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023
GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024
GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687
GlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conference
